Skip to content
AlphaTau logo - link to home page
  • About
  • Technology
  • Therapeutic Targets
  • Clinical Pipeline
  • News Room
    • PR & Blog
    • Events
    • Publications
    • Media
  • FAQ
  • Investors
    • Pipeline
    • Stock Information
    • SEC Filings
    • Investor Events & Presentations
    • Corporate Governance
  • About
  • Technology
  • Therapeutic Targets
  • Clinical Pipeline
  • News Room
    • PR & Blog
    • Events
    • Publications
    • Media
  • FAQ
  • Investors
    • Pipeline
    • Stock Information
    • SEC Filings
    • Investor Events & Presentations
    • Corporate Governance
  • Patients

Alpha Tau CFO Raphi Levy breaks down Alpha DaRT on The Big Biz Show

The Next Big Thing – Interview with Uzi Sofer, Alpha Tau CEO on Alpha Tau, Alpha DaRT and leadership

Tel Aviv – New York – Interview with Alpha Tau CEO following regulatory approval for Alpha DaRT in Japan

Smart Money Circle Show Hosted By Adam Sarhan – Interview with Alpha Tau CFO, Raphi Levy

How recurrent disease is driving the search for new treatment options

Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT

Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study

FDA Receives Pre-Market Approval Module for Novel Recurrent CSCC Therapy

Brain tumor breakthrough: First patient receives Alpha DaRT radiation at OSU

Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference

Next →

Contact us for more information

Linkedin-in X-twitter Youtube Facebook-f

Alpha Tau Medical Limited 2026 © All rights reserved

Contact Us

info@alphatau.com

Subscribe to our upcoming newsletter

ALPHA TAU MEDICAL


  • Privacy Policy
  • News & PR
  • Investors
  • Contact
  • Privacy Policy
  • News & PR
  • Investors
  • Contact

face 2 face – Web Development

Alpha Tau Medical 2026 © All Rights Reserved

Accessibility Adjustments

Powered by OneTap

How long do you want to hide the toolbar?
Hide Toolbar Duration
Select your accessibility profile
Vision Impaired Mode
Enhances website's visuals
Seizure Safe Profile
Clear flashes & reduces color
ADHD Friendly Mode
Focused browsing, distraction-free
Blindness Mode
Reduces distractions, improves focus
Epilepsy Safe Mode
Dims colors and stops blinking
Content Modules
Font Size

Default

Line Height

Default

Color Modules
Orientation Modules
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking \"Accept\", you consent to our use of cookies